Phase I study of oral S-1 plus Gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer

Trial Profile

Phase I study of oral S-1 plus Gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer

Completed
Phase of Trial: Phase I

Latest Information Update: 12 May 2016

At a glance

  • Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
  • Indications Pancreatic cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Nov 2012 Planned End Date (31 Dec 2012) added as reported by University Hospital Medical Information Network - Japan record.
    • 07 May 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan
    • 18 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top